{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:42Z","timestamp":1791849402279,"version":"4.3.4"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Drug Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Efflux pumps are widely viewed as antibiotic resistance determinants, yet their roles in stress adaptation, virulence, quorum sensing, and biofilm formation make them context-dependent therapeutic targets. This Perspective distinguishes four efflux intervention strategies: direct inhibition, bioenergetic or membrane-mediated suppression, regulatory modulation, and dual-effect approaches. We examine why promising in vitro findings rarely translate clinically and argue that efflux-targeting strategies require defined therapeutic objectives and integrated multidisciplinary approaches.<\/jats:p>","DOI":"10.1038\/s44386-026-00083-0","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:03:36Z","timestamp":1791806616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efflux modulation as an antimicrobial strategy: mechanisms and translational perspectives"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5134-719X","authenticated-orcid":false,"given":"Waleska Stephanie","family":"da Cruz Nizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-0383","authenticated-orcid":false,"given":"Cesar Augusto","family":"Roque-Borda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heitor Leoc\u00e1dio","family":"de Souza Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subham Kumar","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zidane","family":"Qriouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia Bagliotti","family":"Meneguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6969-3963","authenticated-orcid":false,"given":"Fernando Rog\u00e9rio","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"83_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","volume":"149","author":"A Sharma","year":"2019","unstructured":"Sharma, A., Gupta, V. K. & Pathania, R. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian J. Med. Res. 149, 129\u2013145 (2019).","journal-title":"Indian J. Med. Res."},{"key":"83_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01858-24","volume":"69","author":"L Xie","year":"2025","unstructured":"Xie, L. et al. Contribution of RND superfamily multidrug efflux pumps AdeABC, AdeFGH, and AdeIJK to antimicrobial resistance and virulence factors in multidrug-resistant Acinetobacter baumannii AYE. Antimicrob. Agents Chemother. 69, e0185824 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83_CR3","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1128\/AAC.03728-14","volume":"58","author":"E Sugawara","year":"2014","unstructured":"Sugawara, E. & Nikaido, H. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli. Antimicrob. Agents Chemother. 58, 7250\u20137257 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83_CR4","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1128\/AAC.45.12.3375-3380.2001","volume":"45","author":"S Magnet","year":"2001","unstructured":"Magnet, S., Courvalin, P. & Lambert, T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45, 3375\u20133380 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83_CR5","doi-asserted-by":"crossref","unstructured":"Teelucksingh, T., Thompson, L. K. & Cox, G. The Evolutionary Conservation of Escherichia coli Drug Efflux Pumps Supports Physiological Functions. J. Bacteriol. 202, e00367\u201320 (2020).","DOI":"10.1128\/JB.00367-20"},{"key":"83_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1128\/JCM.00827-10","volume":"49","author":"T Yasufuku","year":"2011","unstructured":"Yasufuku, T. et al. Correlation of Overexpression of Efflux Pump Genes with Antibiotic Resistance in Escherichia coli Strains Clinically Isolated from Urinary Tract Infection Patients. J. Clin. Microbiol. 49, 189\u2013194 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"83_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/mdr.2006.9990","volume":"13","author":"D Keeney","year":"2007","unstructured":"Keeney, D., Ruzin, A. & Bradford, P. A. RamA, a Transcriptional Regulator, and AcrAB, an RND-Type Efflux Pump, are Associated with Decreased Susceptibility to Tigecycline in Enterobacter cloacae. Microbial Drug Resistance 13, 1\u20136 (2007).","journal-title":"Microbial Drug Resistance"},{"key":"83_CR8","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/jac\/dks228","volume":"67","author":"S Baugh","year":"2012","unstructured":"Baugh, S., Ekanayaka, A. S., Piddock, L. J. V. & Webber, M. A. Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. Journal of Antimicrobial Chemotherapy 67, 2409\u20132417 (2012).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"83_CR9","doi-asserted-by":"publisher","unstructured":"Richmond, G. E. et al. The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner. mBio 7, https:\/\/doi.org\/10.1128\/mbio.00430-16 (2016).","DOI":"10.1128\/mbio.00430-16"},{"key":"83_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.1063","volume":"9","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Biofilm formation in Acinetobacter baumannii was inhibited by PA\u03b2N while it had no association with antibiotic resistance. Microbiologyopen 9, e1063 (2020).","journal-title":"Microbiologyopen"},{"key":"83_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/antibiotics12020419","volume":"12","author":"OA Abd El-Rahman","year":"2023","unstructured":"Abd El-Rahman, O. A., Rasslan, F., Hassan, S. S., Ashour, H. M. & Wasfi, R. The RND Efflux Pump Gene Expression in the Biofilm Formation of Acinetobacter baumannii. Antibiotics 12, 419 (2023).","journal-title":"Antibiotics"},{"key":"83_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7883\/yoken.JJID.2020.765","volume":"74","author":"C-M Kim","year":"2021","unstructured":"Kim, C.-M., Park, G., Ko, Y. J., Kang, S.-H. & Jang, S. J. Relationships between Relative Expression of RND Efflux Pump Genes, H33342 Efflux Activity, Biofilm-Forming Activity, and Antimicrobial Resistance in Acinetobacter baumannii Clinical Isolates. Jpn. J. Infect. Dis. 74, 499\u2013506 (2021).","journal-title":"Jpn. J. Infect. Dis."},{"key":"83_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2180-12-70","volume":"12","author":"S Minagawa","year":"2012","unstructured":"Minagawa, S. et al. RND type efflux pump system MexAB-OprM of Pseudomonas aeruginosa selects bacterial languages, 3-oxo-acyl-homoserine lactones, for cell-to-cell communication. BMC Microbiol 12, 70 (2012).","journal-title":"BMC Microbiol"},{"key":"83_CR14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1128\/JB.181.4.1203-1210.1999","volume":"181","author":"JP Pearson","year":"1999","unstructured":"Pearson, J. P., Van Delden, C. & Iglewski, B. H. Active Efflux and Diffusion Are Involved in Transport of Pseudomonas aeruginosa Cell-to-Cell Signals. J. Bacteriol. 181, 1203\u20131210 (1999).","journal-title":"J. Bacteriol."},{"key":"83_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.15171\/jlms.2018.30","volume":"9","author":"P Rezaie","year":"2018","unstructured":"Rezaie, P., Pourhajibagher, M., Chiniforush, N., Hosseini, N. & Bahador, A. The Effect of Quorum-Sensing and Efflux Pumps Interactions in Pseudomonas aeruginosa Against Photooxidative Stress. J. Lasers Med. Sci. 9, 161\u2013167 (2018).","journal-title":"J. Lasers Med. Sci."},{"key":"83_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1365-2958.2002.02773.x","volume":"43","author":"S Rahmati","year":"2002","unstructured":"Rahmati, S., Yang, S., Davidson, A. L. & Zechiedrich, E. L. Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol. Microbiol. 43, 677\u2013685 (2002).","journal-title":"Mol. Microbiol."},{"key":"83_CR17","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1128\/AAC.48.4.1320-1328.2004","volume":"48","author":"H Maseda","year":"2004","unstructured":"Maseda, H. et al. Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48, 1320\u20131328 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83_CR18","doi-asserted-by":"publisher","first-page":"E3538","DOI":"10.1073\/pnas.1600424113","volume":"113","author":"H Sakhtah","year":"2016","unstructured":"Sakhtah, H. et al. The Pseudomonas aeruginosa efflux pump MexGHI-OpmD transports a natural phenazine that controls gene expression and biofilm development. Proc. Natl. Acad. Sci. USA. 113, E3538\u2013E3547 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"83_CR19","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1021\/acs.chemrev.1c00055","volume":"121","author":"I Alav","year":"2021","unstructured":"Alav, I. et al. Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria. Chem. Rev. 121, 5479\u20135596 (2021).","journal-title":"Chem. Rev."},{"key":"83_CR20","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1046\/j.1365-2958.2003.03531.x","volume":"48","author":"EY Rosenberg","year":"2003","unstructured":"Rosenberg, E. Y., Bertenthal, D., Nilles, M. L., Bertrand, K. P. & Nikaido, H. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol. Microbiol. 48, 1609\u20131619 (2003).","journal-title":"Mol. Microbiol."},{"key":"83_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/cb100390w","volume":"6","author":"K Schirner","year":"2011","unstructured":"Schirner, K., Stone, L. K. & Walker, S. ABC transporters required for export of wall teichoic acids do not discriminate between different main chain polymers. ACS Chem. Biol. 6, 407\u2013412 (2011).","journal-title":"ACS Chem. Biol."},{"key":"83_CR22","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1021\/acsinfecdis.4c00091","volume":"10","author":"M Duffey","year":"2024","unstructured":"Duffey, M. et al. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps. ACS Infect. Dis. 10, 1458\u20131482 (2024).","journal-title":"ACS Infect. Dis."},{"key":"83_CR23","first-page":"1","volume":"5","author":"P Ray","year":"2021","unstructured":"Ray, P., Nguyen, K., Nguyen, T. & Sachdev, S. Resurrecting the Dead: Mitigating Efflux-Pump Inhibitor Toxicity using a Liposomal Delivery System to Recover Efficacy of Antimicrobial Drugs. Undergraduate Research in Natural and Clinical Science and Technology Journal 5, 1\u20137 (2021).","journal-title":"Undergraduate Research in Natural and Clinical Science and Technology Journal"},{"key":"83_CR24","doi-asserted-by":"publisher","first-page":"1440996","DOI":"10.1155\/2022\/1440996","volume":"2022","author":"NS Mac\u00eado","year":"2022","unstructured":"Mac\u00eado, N. S. et al. Inhibition of Staphylococcus aureus Efflux Pump by O-Eugenol and Its Toxicity in Drosophila melanogaster Animal Model. Biomed Res. Int. 2022, 1440996 (2022).","journal-title":"Biomed Res. Int."},{"key":"83_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ddstr.2006.05.005","volume":"3","author":"K Poole","year":"2006","unstructured":"Poole, K. & Lomovskaya, O. Can efflux inhibitors really counter resistance?. Drug Discov. Today Ther. Strateg. 3, 145\u2013152 (2006).","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"83_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/jac\/42.6.807","volume":"42","author":"FJ Schmitz","year":"1998","unstructured":"Schmitz, F. J. et al. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 42, 807\u2013810 (1998).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"83_CR27","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1073\/pnas.88.11.4781","volume":"88","author":"AA Neyfakh","year":"1991","unstructured":"Neyfakh, A. A., Bidnenko, V. E. & Chen, L. B. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proceedings of the National Academy of Sciences 88, 4781\u20134785 (1991).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"83_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/204141","volume":"2013","author":"S Kumar","year":"2013","unstructured":"Kumar, S., Mukherjee, M. M. & Varela, M. F. Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily. Int. J. Bacteriol. 2013, 1\u201315 (2013).","journal-title":"Int. J. Bacteriol."},{"key":"83_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2174\/1386207319666160720101502","volume":"19","author":"D Choudhury","year":"2016","unstructured":"Choudhury, D. et al. Screening of Natural Products and Derivatives for the Identification of RND Efflux Pump Inhibitors. Comb. Chem. High Throughput Screen. 19, 705\u2013713 (2016).","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"83_CR30","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.bmc.2015.03.016","volume":"23","author":"ST Nguyen","year":"2015","unstructured":"Nguyen, S. T. et al. Structure-Activity Relationships of a Novel Pyranopyridine Series of Gram-negative Bacterial Efflux Pump Inhibitors. Bioorg. Med. Chem. 23, 2024\u20132034 (2015).","journal-title":"Bioorg. Med. Chem."},{"key":"83_CR31","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.bmc.2005.10.043","volume":"14","author":"K Yoshida","year":"2006","unstructured":"Yoshida, K. et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position. Bioorg. Med. Chem. 14, 1993\u20132004 (2006).","journal-title":"Bioorg. Med. Chem."},{"key":"83_CR32","doi-asserted-by":"publisher","first-page":"8506","DOI":"10.1016\/j.bmc.2006.08.037","volume":"14","author":"K Yoshida","year":"2006","unstructured":"Yoshida, K. et al. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: Exploration of aromatic substituents. Bioorg. Med. Chem. 14, 8506\u20138518 (2006).","journal-title":"Bioorg. Med. Chem."},{"key":"83_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tibs.2013.11.002","volume":"39","author":"K Wong","year":"2014","unstructured":"Wong, K., Ma, J., Rothnie, A., Biggin, P. C. & Kerr, I. D. Towards understanding promiscuity in multidrug efflux pumps. Trends Biochem. Sci. 39, 8\u201316 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"83_CR34","doi-asserted-by":"publisher","first-page":"e0259915","DOI":"10.1371\/journal.pone.0259915","volume":"16","author":"A Sanchez-Carbonel","year":"2021","unstructured":"Sanchez-Carbonel, A. et al. The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii. PLoS One 16, e0259915 (2021).","journal-title":"PLoS One"},{"key":"83_CR35","doi-asserted-by":"crossref","unstructured":"Osei Sekyere, J. & Amoako, D. G. Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) Reverses Resistance to Colistin, but Not to Carbapenems and Tigecycline in Multidrug-Resistant Enterobacteriaceae. Front. Microbiol. 8, 1\u20139 (2017).","DOI":"10.3389\/fmicb.2017.00228"},{"key":"83_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3947\/ic.2015.47.2.98","volume":"47","author":"M Adabi","year":"2015","unstructured":"Adabi, M. et al. Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor. Infect. Chemother. 47, 98\u2013104 (2015).","journal-title":"Infect. Chemother."},{"key":"83_CR37","doi-asserted-by":"publisher","first-page":"17854","DOI":"10.1039\/D0RA03124K","volume":"10","author":"X Lu","year":"2020","unstructured":"Lu, X. et al. Effect of new carbonyl cyanide aromatic hydrazones on biofilm inhibition against methicillin resistant Staphylococcus aureus. RSC Adv 10, 17854\u201317861 (2020).","journal-title":"RSC Adv"},{"key":"83_CR38","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/jor.23723","volume":"36","author":"DH Dusane","year":"2018","unstructured":"Dusane, D. H. et al. Targeting intracellular Staphylococcus aureus to lower recurrence of orthopaedic infection. J. Orthop. Res. 36, 1086\u20131092 (2018).","journal-title":"J. Orthop. Res."},{"key":"83_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep44419","volume":"7","author":"D Sinha","year":"2017","unstructured":"Sinha, D. et al. Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains. Sci. Rep. 7, 44419 (2017).","journal-title":"Sci. Rep."},{"key":"83_CR40","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2147\/IDR.S303113","volume":"14","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against Mycobacterium abscessus. Infect. Drug Resist. 14, 1199\u20131208 (2021).","journal-title":"Infect. Drug Resist."},{"key":"83_CR41","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.3390\/ijms24032106","volume":"24","author":"M Zoaiter","year":"2023","unstructured":"Zoaiter, M., Zeaiter, Z., Mediannikov, O., Sokhna, C. & Fournier, P.-E. Carbonyl Cyanide 3-Chloro Phenyl Hydrazone (CCCP) Restores the Colistin Sensitivity in Brucella intermedia. Int. J. Mol. Sci. 24, 2106 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"83_CR42","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/jac\/dkl081","volume":"57","author":"S Pannek","year":"2006","unstructured":"Pannek, S. et al. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-\u03b2-naphthylamide. Journal of Antimicrobial Chemotherapy 57, 970\u2013974 (2006).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"83_CR43","doi-asserted-by":"publisher","first-page":"e60666","DOI":"10.1371\/journal.pone.0060666","volume":"8","author":"RP Lamers","year":"2013","unstructured":"Lamers, R. P., Cavallari, J. F. & Burrows, L. L. The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PA\u03b2N) Permeabilizes the Outer Membrane of Gram-Negative Bacteria. PLoS One 8, e60666 (2013).","journal-title":"PLoS One"},{"key":"83_CR44","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1128\/AAC.35.11.2282","volume":"35","author":"WE Alborn","year":"1991","unstructured":"Alborn, W. E., Allen, N. E. & Preston, D. A. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother. 35, 2282\u20132287 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83_CR45","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","volume":"47","author":"JA Silverman","year":"2003","unstructured":"Silverman, J. A., Perlmutter, N. G. & Shapiro, H. M. Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47, 2538\u20132544 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83_CR46","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1128\/AAC.01121-07","volume":"52","author":"A Muthaiyan","year":"2008","unstructured":"Muthaiyan, A., Silverman, J. A., Jayaswal, R. K. & Wilkinson, B. J. Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane Depolarization. Antimicrob. Agents Chemother. 52, 980\u2013990 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"83_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1039\/D0MO00015A","volume":"16","author":"M Li","year":"2020","unstructured":"Li, M. et al. Pan-transcriptomic analysis identified common differentially expressed genes of Acinetobacter baumannii in response to polymyxin treatments. Mol. Omics 16, 327\u2013338 (2020).","journal-title":"Mol. Omics"},{"key":"83_CR48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/DDDT.S405579","volume":"17","author":"J Peng","year":"2023","unstructured":"Peng, J. et al. Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo. Drug Des. Devel. Ther. 17, 977\u2013992 (2023).","journal-title":"Drug Des. Devel. Ther."},{"key":"83_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91765-4","volume":"11","author":"M Dong","year":"2021","unstructured":"Dong, M. et al. BING, a novel antimicrobial peptide isolated from Japanese medaka plasma, targets bacterial envelope stress response by suppressing cpxR expression. Sci. Rep. 11, 12219 (2021).","journal-title":"Sci. Rep."},{"key":"83_CR50","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.1111\/1462-2920.15511","volume":"23","author":"P Laborda","year":"2021","unstructured":"Laborda, P., Alcalde-Rico, M., Chini, A., Mart\u00ednez, J. L. & Hernando-Amado, S. Discovery of inhibitors of Pseudomonas aeruginosa virulence through the search for natural-like compounds with a dual role as inducers and substrates of efflux pumps. Environ. Microbiol. 23, 7396\u20137411 (2021).","journal-title":"Environ. Microbiol."},{"key":"83_CR51","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1128\/JB.180.20.5443-5447.1998","volume":"180","author":"K Evans","year":"1998","unstructured":"Evans, K. et al. Influence of the MexAB-OprM Multidrug Efflux System on Quorum Sensing in Pseudomonas aeruginosa. J. Bacteriol. 180, 5443\u20135447 (1998).","journal-title":"J. Bacteriol."},{"key":"83_CR52","doi-asserted-by":"publisher","first-page":"e24310","DOI":"10.1371\/journal.pone.0024310","volume":"6","author":"MG Lamarche","year":"2011","unstructured":"Lamarche, M. G. & D\u00e9ziel, E. MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS One 6, e24310 (2011).","journal-title":"PLoS One"},{"key":"83_CR53","doi-asserted-by":"crossref","unstructured":"Can\u00e8, C. et al. The antimicrobial peptide Esc(1-21)-1c increases susceptibility of Pseudomonas aeruginosa to conventional antibiotics by decreasing the expression of the MexAB-OprM efflux pump. Front. Chem. 11, 1\u201311 (2023).","DOI":"10.3389\/fchem.2023.1271153"},{"key":"83_CR54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10123-024-00560-4","volume":"28","author":"F Norouzalinia","year":"2025","unstructured":"Norouzalinia, F., Asadpour, L. & Mokhtary, M. Anti-microbial, anti-biofilm, and efflux pump inhibitory effects of ellagic acid\u2013bonded magnetic nanoparticles against Escherichia coli isolates. International Microbiology 28, 563\u2013573 (2025).","journal-title":"International Microbiology"},{"key":"83_CR55","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/jobm.201900712","volume":"60","author":"R Behdad","year":"2020","unstructured":"Behdad, R. et al. Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug-resistant Acinetobacter baumannii clinical isolates. J. Basic Microbiol. 60, 494\u2013507 (2020).","journal-title":"J. Basic Microbiol."},{"key":"83_CR56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/pharmaceutics13040577","volume":"13","author":"DL Gbian","year":"2021","unstructured":"Gbian, D. L. & Omri, A. The Impact of an Efflux Pump Inhibitor on the Activity of Free and Liposomal Antibiotics against Pseudomonas aeruginosa. Pharmaceutics 13, 577 https:\/\/doi.org\/10.3390\/pharmaceutics13040577 (2021).","journal-title":"Pharmaceutics"},{"key":"83_CR57","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1128\/AEM.01310-08","volume":"74","author":"M Kvist","year":"2008","unstructured":"Kvist, M., Hancock, V. & Klemm, P. Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation. Appl. Environ. Microbiol. 74, 7376\u20137382 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"83_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/apm.13015","volume":"128","author":"A Pal","year":"2020","unstructured":"Pal, A. & Tripathi, A. Quercetin inhibits carbapenemase and efflux pump activities among carbapenem-resistant Gram-negative bacteria. APMIS 128, 251\u2013259 (2020).","journal-title":"APMIS"},{"key":"83_CR59","doi-asserted-by":"crossref","unstructured":"Yamaguchi, A., Nakashima, R. & Sakurai, K. Structural basis of RND-type multidrug exporters. Front. Microbiol. 6, 1\u201319 (2015).","DOI":"10.3389\/fmicb.2015.00327"},{"key":"83_CR60","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.resmic.2017.11.001","volume":"169","author":"Z Aron","year":"2018","unstructured":"Aron, Z. & Opperman, T. J. The hydrophobic trap\u2014the Achilles heel of RND efflux pumps. Res. Microbiol. 169, 393\u2013400 (2018).","journal-title":"Res. Microbiol."},{"key":"83_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27146-2","volume":"12","author":"A Ornik-Cha","year":"2021","unstructured":"Ornik-Cha, A. et al. Structural and functional analysis of the promiscuous AcrB and AdeB efflux pumps suggests different drug binding mechanisms. Nat. Commun. 12, 6919 (2021).","journal-title":"Nat. Commun."},{"key":"83_CR62","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s42003-022-04024-1","volume":"5","author":"J Vergalli","year":"2022","unstructured":"Vergalli, J. et al. A framework for dissecting affinities of multidrug efflux transporter AcrB to fluoroquinolones. Commun. Biol. 5, 1062 (2022).","journal-title":"Commun. Biol."},{"key":"83_CR63","doi-asserted-by":"crossref","unstructured":"Lyu, M. et al. Cryo-EM Structures of a Gonococcal Multidrug Efflux Pump Illuminate a Mechanism of Drug Recognition and Resistance. mBio 11, (2020).","DOI":"10.1128\/mBio.00996-20"},{"key":"83_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40232-2","volume":"9","author":"K Sakurai","year":"2019","unstructured":"Sakurai, K. et al. Crystal structures of multidrug efflux pump MexB bound with high-molecular-mass compounds. Sci. Rep. 9, 4359 (2019).","journal-title":"Sci. Rep."},{"key":"83_CR65","doi-asserted-by":"crossref","unstructured":"Whittle, E. E. et al. Efflux Impacts Intracellular Accumulation Only in Actively Growing Bacterial Cells. mBio 12, e02608\u201321 (2021).","DOI":"10.1128\/mBio.02608-21"},{"key":"83_CR66","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Morgan, C. E., Bonomo, R. A. & Yu, E. W. Cryo-EM Structures of the Klebsiella pneumoniae AcrB Multidrug Efflux Pump. mBio 14, e0065923 (2023).","DOI":"10.1128\/mbio.00659-23"},{"key":"83_CR67","doi-asserted-by":"crossref","unstructured":"Chawla, M., Verma, J., Gupta, R. & Das, B. Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance. Front. Microbiol. 13, 1\u201319 (2022).","DOI":"10.3389\/fmicb.2022.887251"},{"key":"83_CR68","doi-asserted-by":"crossref","unstructured":"Narendrakumar, L., Chakraborty, M., Kumari, S., Paul, D. & Das, B. \u03b2-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward. Front. Microbiol. 13, 1\u2013 23 (2023).","DOI":"10.3389\/fmicb.2022.1092556"},{"key":"83_CR69","doi-asserted-by":"publisher","first-page":"104766","DOI":"10.1016\/j.micpath.2021.104766","volume":"152","author":"P Verma","year":"2021","unstructured":"Verma, P., Tiwari, M. & Tiwari, V. Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors. Microb. Pathog. 152, 104766 https:\/\/doi.org\/10.3390\/pharmaceutics13040577 (2021).","journal-title":"Microb. Pathog."},{"key":"83_CR70","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"X-Z Li","year":"2015","unstructured":"Li, X.-Z., Pl\u00e9siat, P. & Nikaido, H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337\u2013418 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"83_CR71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0014-5793(01)02693-X","volume":"503","author":"MLR Lim","year":"2001","unstructured":"Lim, M. L. R., Minamikawa, T. & Nagley, P. The protonophore CCCP induces mitochondrial permeability transition without cytochrome c release in human osteosarcoma cells. FEBS Lett 503, 69\u201374 (2001).","journal-title":"FEBS Lett"},{"key":"83_CR72","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0022-2828(03)00114-7","volume":"35","author":"C Ganote","year":"2003","unstructured":"Ganote, C. Effects of CCCP-induced mitochondrial uncoupling and cyclosporin A on cell volume, cell injury and preconditioning protection of isolated rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 35, 749\u2013759 (2003).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"83_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.addr.2015.03.001","volume":"86","author":"F Montanari","year":"2015","unstructured":"Montanari, F. & Ecker, G. F. Prediction of drug-ABC-transporter interaction-Recent advances and future challenges. Adv. Drug Deliv. Rev. 86, 17\u201326 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"83_CR74","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1093\/jac\/dkad320","volume":"78","author":"AP MacGowan","year":"2023","unstructured":"MacGowan, A. P. et al. Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance. Journal of Antimicrobial Chemotherapy 78, 2869\u20132877 (2023).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"83_CR75","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/molecules24030470","volume":"24","author":"S Schuster","year":"2019","unstructured":"Schuster, S., Bohnert, J. A., Vavra, M., Rossen, J. W. & Kern, W. V. Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-\u03b2-Naphthylamide from Random Mutagenesis. Molecules 24, 470 (2019).","journal-title":"Molecules"},{"key":"83_CR76","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/antibiotics12010180","volume":"12","author":"N Compagne","year":"2023","unstructured":"Compagne, N. et al. Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria. Antibiotics 12, 180 (2023).","journal-title":"Antibiotics"},{"key":"83_CR77","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/antibiotics14080778","volume":"14","author":"F Rouvier","year":"2025","unstructured":"Rouvier, F., Brunel, J.-M., Pag\u00e8s, J.-M. & Vergalli, J. Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps. Antibiotics 14, 778 (2025).","journal-title":"Antibiotics"},{"key":"83_CR78","doi-asserted-by":"crossref","unstructured":"Kumar, V. et al. Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens. Front. Cell. Infect. Microbiol. 13, 1\u201314 (2023).","DOI":"10.3389\/fcimb.2023.1293633"},{"key":"83_CR79","unstructured":"Bombarda, T. R. et al. Antimicrobial Biocomposites Based on Regenerated Cellulose Sponge\/Silver Nanoparticles Obtained by Friendly-Environmental Method as a Promising Material for Tissue Engineering. J. Braz. Chem. Soc. 36, e-20250056 (2025)."},{"key":"83_CR80","doi-asserted-by":"publisher","first-page":"111454","DOI":"10.1016\/j.foodhyd.2025.111454","volume":"167","author":"CA Roque-Borda","year":"2025","unstructured":"Roque-Borda, C. A. et al. Alginate-pectin microparticles embedding self-assembling antimicrobial peptides and resveratrol for antimicrobial and anti-inflammatory applications. Food Hydrocoll 167, 111454 (2025).","journal-title":"Food Hydrocoll"},{"key":"83_CR81","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/acsinfecdis.5c01065","volume":"12","author":"VT Pham","year":"2026","unstructured":"Pham, V. T., De Oliveira, D. M. P., Kuo, A., Walker, M. J. & Smith, M. T. Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants. ACS Infect. Dis. 12, 1794\u20131818 (2026).","journal-title":"ACS Infect. Dis."},{"key":"83_CR82","doi-asserted-by":"crossref","unstructured":"Hada, A. P. S. et al. Exploring allosteric efflux pump inhibitors and the role of bacterial membrane potential in modulating drug resistance. Front. Microbiol. 17, 1\u201315 (2026).","DOI":"10.3389\/fmicb.2026.1802731"},{"key":"83_CR83","doi-asserted-by":"publisher","first-page":"13071","DOI":"10.1021\/acs.jmedchem.6c00060","volume":"69","author":"M Laws","year":"2026","unstructured":"Laws, M. et al. Designing Antibiotics with Inherent Resistance to Efflux as a Strategy to Revive Discovery against Multidrug-Resistant Pathogens. J. Med. Chem. 69, 13071\u201313098 (2026).","journal-title":"J. Med. Chem."},{"key":"83_CR84","doi-asserted-by":"crossref","unstructured":"Nishino, K., Yamasaki, S., Nakashima, R., Zwama, M. & Hayashi-Nishino, M. Function and Inhibitory Mechanisms of Multidrug Efflux Pumps. Front. Microbiol. 12, 1\u201313 (2021).","DOI":"10.3389\/fmicb.2021.737288"},{"key":"83_CR85","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/jac\/dkg225","volume":"51","author":"F Van Bambeke","year":"2003","unstructured":"Van Bambeke, F. Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. Journal of Antimicrobial Chemotherapy 51, 1067\u20131077 (2003).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"83_CR86","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/antibiotics12091417","volume":"12","author":"S Zhang","year":"2023","unstructured":"Zhang, S., Wang, J. & Ahn, J. Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens. Antibiotics 12, 1417 (2023).","journal-title":"Antibiotics"},{"key":"83_CR87","doi-asserted-by":"crossref","unstructured":"Gaurav, A., Bakht, P., Saini, M., Pandey, S. & Pathania, R. Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiology (N. Y). 169, 1\u201313 (2023).","DOI":"10.1099\/mic.0.001333"},{"key":"83_CR88","doi-asserted-by":"crossref","unstructured":"Chetri, S. The culmination of multidrug-resistant efflux pumps vs. meager antibiotic arsenal era: Urgent need for an improved new generation of EPIs. Front. Microbiol. 14, (2023).","DOI":"10.3389\/fmicb.2023.1149418"},{"key":"83_CR89","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3390\/jcm14082823","volume":"14","author":"IH Cerda","year":"2025","unstructured":"Cerda, I. H. et al. Trends in Celecoxib Prescribing: A Single Institution 16-Month Review. J. Clin. Med. 14, 2823 (2025).","journal-title":"J. Clin. Med."},{"key":"83_CR90","doi-asserted-by":"crossref","unstructured":"Annamanedi, M., Varma, G. Y. N., Anuradha, K. & Kalle, A. M. Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens. Front. Microbiol. 8, 1\u201311 (2017).","DOI":"10.3389\/fmicb.2017.00805"},{"key":"83_CR91","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1021\/acs.jmedchem.6b01439","volume":"60","author":"A Astolfi","year":"2017","unstructured":"Astolfi, A. et al. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors. J. Med. Chem. 60, 1598\u20131604 (2017).","journal-title":"J. Med. Chem."},{"key":"83_CR92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0924-8579(99)00154-5","volume":"14","author":"JL Munoz-Bellido","year":"2000","unstructured":"Munoz-Bellido, J. L. & Munoz-Criado, S. & Garc\u0131\u0300a-Rodr\u0131\u0300guez, J. A. Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors. Int. J. Antimicrob. Agents 14, 177\u2013180 (2000).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"83_CR93","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/jac\/dkr258","volume":"66","author":"JA Bohnert","year":"2011","unstructured":"Bohnert, J. A., Szymaniak-Vits, M., Schuster, S. & Kern, W. V. Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli. Journal of Antimicrobial Chemotherapy 66, 2057\u20132060 (2011).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"83_CR94","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1007\/s00253-019-09954-1","volume":"103","author":"H Abdel-Halim","year":"2019","unstructured":"Abdel-Halim, H., Al Dajani, A., Abdelhalim, A. & Abdelmalek, S. The search of potential inhibitors of the AcrAB\u2013TolC system of multidrug-resistant Escherichia coli: an in silico approach. Appl. Microbiol. Biotechnol. 103, 6309\u20136318 (2019).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"83_CR95","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1021\/acsinfecdis.3c00350","volume":"9","author":"LA Pisoni","year":"2023","unstructured":"Pisoni, L. A., Semple, S. J., Liu, S., Sykes, M. J. & Venter, H. Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in Escherichia coli. ACS Infect. Dis. 9, 2504\u20132522 (2023).","journal-title":"ACS Infect. Dis."},{"key":"83_CR96","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12300","volume":"500","author":"R Nakashima","year":"2013","unstructured":"Nakashima, R. et al. Structural basis for the inhibition of bacterial multidrug exporters. Nature 500, 102\u2013106 (2013).","journal-title":"Nature"},{"key":"83_CR97","doi-asserted-by":"publisher","first-page":"20637","DOI":"10.1073\/pnas.1218348109","volume":"109","author":"AV Vargiu","year":"2012","unstructured":"Vargiu, A. V. & Nikaido, H. Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations. Proceedings of the National Academy of Sciences 109, 20637\u201320642 (2012).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"83_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2016.05.007","volume":"33","author":"Z Aron","year":"2016","unstructured":"Aron, Z. & Opperman, T. J. Optimization of a novel series of pyranopyridine RND efflux pump inhibitors. Curr. Opin. Microbiol. 33, 1\u20136 (2016).","journal-title":"Curr. Opin. Microbiol."},{"key":"83_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrmicro732","volume":"1","author":"U Theuretzbacher","year":"2025","unstructured":"Theuretzbacher, U., Jumde, R. P., Hennessy, A., Cohn, J. & Piddock, L. J. V. Global health perspectives on antibacterial drug discovery and the preclinical pipeline. Nat. Rev. Microbiol. 1, 17 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"83_CR100","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1872208316666220802151129","volume":"17","author":"A Tripathi","year":"2023","unstructured":"Tripathi, A., Misra, K., Dhanuka, R. & Singh, J. P. Artificial Intelligence in Accelerating Drug Discovery and Development. Recent Pat. Biotechnol. 17, 9\u201323 (2023).","journal-title":"Recent Pat. Biotechnol."},{"key":"83_CR101","doi-asserted-by":"crossref","unstructured":"Banerjee, D., Rajput, D., Banerjee, S. & Saharan, V. A. Artificial Intelligence and Its Applications in Drug Discovery, Formulation Development, and Healthcare. in Computer Aided Pharmaceutics and Drug Delivery: An Application Guide for Students and Researchers of Pharmaceutical Sciences (ed. Saharan, V. A.) 309\u2013380 (Springer Nature, Singapore, 2022).","DOI":"10.1007\/978-981-16-5180-9_11"},{"key":"83_CR102","doi-asserted-by":"crossref","unstructured":"Bagdad, Y. & Miteva, M. A. Recent applications of artificial intelligence in discovery of new antibacterial agents. Advances and Applications in Bioinformatics Chem. 17, 139\u2013157 (2024).","DOI":"10.2147\/AABC.S484321"},{"key":"83_CR103","first-page":"1333","volume":"169","author":"A Gaurav","year":"2023","unstructured":"Gaurav, A., Bakht, P., Saini, M., Pandey, S. & Pathania, R. Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiology (N. Y). 169, 1333 (2023).","journal-title":"Microbiology (N. Y)."},{"key":"83_CR104","doi-asserted-by":"crossref","unstructured":"Saxena, D., Maitra, R., Dasgupta, A. & Chopra, S. Alternative Approaches to Counter Multidrug-Resistant Bacterial Pathogens. Emerging Paradigms for Antibiotic-Resistant Infections: Beyond the Pill 69\u2013121 (2024).","DOI":"10.1007\/978-981-97-5272-0_5"},{"key":"83_CR105","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/ph16101467","volume":"16","author":"KM Chung","year":"2023","unstructured":"Chung, K. M., Liau, X. L. & Tang, S. S. Bacteriophages and their host range in multidrug-resistant bacterial disease treatment. Pharmaceuticals 16, 1467 (2023).","journal-title":"Pharmaceuticals"},{"key":"83_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012361","volume":"20","author":"S Kraus","year":"2024","unstructured":"Kraus, S. et al. Phage-induced efflux down-regulation boosts antibiotic efficacy. PLoS Pathog 20, e1012361 (2024).","journal-title":"PLoS Pathog"},{"key":"83_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85334-2","volume":"15","author":"D Lee","year":"2025","unstructured":"Lee, D. et al. A CRISPR-Cas9 system protecting E. coli against acquisition of antibiotic resistance genes. Sci. Rep. 15, 1545 (2025).","journal-title":"Sci. Rep."},{"key":"83_CR108","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","volume":"172","author":"L Imamovic","year":"2018","unstructured":"Imamovic, L. et al. Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections. Cell 172, 121\u2013134.e14 (2018).","journal-title":"Cell"},{"key":"83_CR109","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1093\/jac\/dkac166","volume":"77","author":"X Wan","year":"2022","unstructured":"Wan, X. et al. Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli. J. Antimicrob. Chemother. 77, 2158\u20132166 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"83_CR110","doi-asserted-by":"crossref","unstructured":"da Cruz Nizer, W. S., Adams, M. E., Inkovskiy, V., Beaulieu, C. & Overhage, J. The secondary metabolite hydrogen cyanide protects Pseudomonas aeruginosa against sodium hypochlorite-induced oxidative stress. Front. Microbiol. 14, 1\u201316 (2023).","DOI":"10.3389\/fmicb.2023.1294518"},{"key":"83_CR111","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/08927014.2024.2395378","volume":"40","author":"WS da Cruz Nizer","year":"2024","unstructured":"da Cruz Nizer, W. S. et al. Genetic determinants of increased sodium hypochlorite and ciprofloxacin susceptibility in Pseudomonas aeruginosa PA14 biofilms. Biofouling 40, 563\u2013579 (2024).","journal-title":"Biofouling"},{"key":"83_CR112","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/1040841X.2023.2233603","volume":"50","author":"I Alav","year":"2024","unstructured":"Alav, I. & Buckner, M. M. C. Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes. Crit. Rev. Microbiol. 50, 993\u20131010 (2024).","journal-title":"Crit. Rev. Microbiol."},{"key":"83_CR113","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/antibiotics14040371","volume":"14","author":"G Cusumano","year":"2025","unstructured":"Cusumano, G., Flores, G. A., Venanzoni, R. & Angelini, P. The Impact of Antibiotic Therapy on Intestinal Microbiota: Dysbiosis, Antibiotic Resistance, and Restoration Strategies. Antibiotics 14, 371 (2025).","journal-title":"Antibiotics"},{"key":"83_CR114","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/antibiotics12081241","volume":"12","author":"A Turban","year":"2023","unstructured":"Turban, A., Gu\u00e9rin, F., Dinh, A. & Cattoir, V. Updated Review on Clinically-Relevant Properties of Delafloxacin. Antibiotics 12, 1241 (2023).","journal-title":"Antibiotics"},{"key":"83_CR115","doi-asserted-by":"publisher","unstructured":"Alexandre, K., Murillo-Torres, M., Docobo-P\u00e9rez, F., Pascual, \u00c1. & Rodr\u00edguez-Mart\u00ednez, J. M. Effect of pH on antimicrobial activity of delafloxacin against Escherichia coli isogenic strains carrying diverse chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/spectrum.02338-25 (2025).","DOI":"10.1128\/spectrum.02338-25"},{"key":"83_CR116","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1093\/jac\/dkaa209","volume":"75","author":"LD Saravolatz","year":"2020","unstructured":"Saravolatz, L. D., Pawlak, J. M. & Wegner, C. Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid. Journal of Antimicrobial Chemotherapy 75, 2605\u20132608 (2020).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"83_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78124-9","volume":"14","author":"A Kubicsk\u00f3","year":"2024","unstructured":"Kubicsk\u00f3, A., Kamotsay, K., Szab\u00f3, D. & Kocsis, B. Analysis of molecular mechanisms of delafloxacin resistance in Escherichia coli. Sci. Rep. 14, 26423 (2024).","journal-title":"Sci. Rep."},{"key":"83_CR118","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/antibiotics14010062","volume":"14","author":"A Kubicsk\u00f3","year":"2025","unstructured":"Kubicsk\u00f3, A., Juh\u00e1sz, J., Kamotsay, K., Szabo, D. & Kocsis, B. Detection of Delafloxacin Resistance Mechanisms in Multidrug-Resistant Klebsiella pneumoniae. Antibiotics 14, 62 (2025).","journal-title":"Antibiotics"}],"container-title":["npj Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00083-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00083-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00083-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:34:12Z","timestamp":1791848052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00083-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["83"],"URL":"https:\/\/doi.org\/10.1038\/s44386-026-00083-0","relation":{},"ISSN":["3005-1452"],"issn-type":[{"value":"3005-1452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"48"}}